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Abstract
The culture of endothelial progenitor cells (EPC) provides an excellent tool to research on EPC biology and vascular regeneration and vasculo-
genesis. The use of different protocols to obtain EPC cultures makes it difficult to obtain comparable results in different groups. This work offers
a systematic comparison of the main variables of most commonly used protocols for EPC isolation, culture and functional evaluation. Peripheral
blood samples from healthy individuals were recovered and mononuclear cells were cultured. Different recovery and culture conditions were
tested: blood volume, blood anticoagulant, coating matrix and percentage of foetal bovine serum (FBS) in culture media. The success of culture
procedure, first colonies of endothelial cells appearance time, correlation with number of circulating EPC (cEPC) and functional comparison with
human umbilical vein endothelial cells (HUVEC) were studied. The use of heparin, a minimum blood volume of 30 ml, fibronectin as a coating
matrix and endothelial growing media-2 supplemented with 20% FBS increased the success of obtaining EPC cultures up to 80% of the pro-
cessed samples while reducing EPC colony appearance mean time to a minimum of 13 days. Blood samples exhibiting higher cEPC numbers
resulted in reduced EPC colony appearance mean time. Cells isolated by using this combination were endothelial cell-like EPCs morphological
and phenotypically. Functionally, cultured EPC showed decreased growing and vasculogenic capacity when compared to HUVEC. Thus, above-
mentioned conditions allow the isolation and culture of EPC with smaller blood volumes and shorter times than currently used protocols.
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Introduction
Vasculogenesis in adults was for first time reported after the identifi-
cation and characterization of a population of EPC derived from
peripheral blood [1]. Endothelial progenitor cells are incorporated into
new vessels undergoing active angiogenesis. This process of post-
natal vasculogenesis refers to the formation of new blood vessels
from progenitor cells in the adult and has been associated with differ-
ent physiological functions [2] and pathological disorders as cancer
[3], cardiovascular diseases (CVD) [4, 5] and diabetes [6].
Since EPC were discovered, a great deal of literature has empha-
sized the importance of such progenitor cells in the maintenance of
endothelial integrity by both exerting a paracrine effect to promote
angiogenesis and integrating themselves into new vessels [6, 7].
Actually, an inverse correlation between EPC numbers and cardiovas-
cular risk factors has been reported in patients with cardiovascular
risk, but no history of CVD [8].
Besides the number of EPCs, the progenitor cell function could be
affected by individual factors, such as cardiovascular risk factors, dif-
ferent drug treatments, hormone levels and others [9]. The study of
EPC function requires obtaining EPC cultures, but one of the draw-
backs existing is the lack of a simple and reproducible method to iso-
late, cultivate and expand EPC. It could be as a result of the small
fraction at which these cells are found circulating level, representing
only about 0.0001% of total mononuclear cells (MNC) of peripheral
blood in human adults [10]. Culture of EPC has been performed in
several ways, for early and late EPC [11], although a systematic and
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detailed protocol to obtain replicate data on cultured EPC is still
required.
Moreover, a potential clinical use of cultured EPC has been
proposed, including re-endothelialization of injured vessels, reduc-
ing atherosclerotic disease appearance and progression and
revascularization of infarcted regions [12]. Endothelial progenitor
cells have also been proposed as potential therapeutic tools for
gene therapy in growing cancers [13].
In the present study, we evaluated the influence of different culture
conditions in obtaining EPC cultures, and we tested EPC functional
capacity and compared it with HUVEC, widely used as a laboratory
model system for studies on endothelial cell function and pathology.
Therefore, we proposed an affordable and reproducible method to
obtain EPC cultures to perform functional cell assays.
Materials and methods
Study design
This study was designed to compare different culture conditions for the
best way to isolate and to obtain cultured, functional EPC. First, we selected
the optimal blood sample withdrawal conditions in terms of volume and
anticoagulant. Second, the culture conditions (extracellular matrix, culture
media composition) were analysed. Finally, the functional capacity of the
cultured EPC (measured in terms of cell growth and adhesion, cell prolifer-
ation and vasculogenesis) was the parameter to ensure the best culture
conditions of the obtained cells, taking HUVEC as standard reference.
Blood samples
Peripheral blood samples were obtained from 60 healthy individuals at
the Cardiology Service, Hospital Clinico of Valencia, in accordance with
institutional guidelines. The characteristics of the participants enrolled
are presented in Table S1.
Different blood volumes (60 ml) were withdrawn by venipuncture
and were collected in tubes containing different anticoagulants: ethylen-
ediaminetetraacetic acid (EDTA), heparin and sodium citrate (Vacutainer,
Becton Dickinson, San Agustin del Guadalix, Madrid, Spain). To avoid
sample contamination with mature endothelial cells (EC), first 6 ml of
collected blood was discarded.
Blood samples were processed within 2 hr after extraction. To
assess the effect of time sampling on EPC culture yields, a set of sam-
ples were left on a blood roller mixer at room temperature and were
processed 24 hrs after withdrawal.
This investigation conforms to the principles outlined in the Declara-
tion of Helsinki, was approved by the Ethical Committee of Clinical
Research of the INCLIVA, Hospital Clinico of Valencia, Spain, and writ-
ten informed consent was obtained from all donors.
Mononuclear cell isolation
Mononuclear cells from peripheral blood samples were isolated
as described before [14]. Briefly, non-diluted blood was layered over
Lymphoprep (Axis-shield, Oslo, Norway) in a volume ratio 2:1, and
centrifuged at 800 rcf for 30 min. at room temperature. Mononuclear
cells from interphase were collected and washed twice with 6% foetal
bovine serum (FBS) (Gibco, Life technologies, Alcobendas, Spain) in
Dulbeco’s PBS solution (Gibco).
Endothelial progenitor cell culture
Mononuclear cells isolated from blood samples were collected in endo-
thelial growing media (EGM)-2 complete medium with the following
composition (Lonza, Lonza Iberica, Barcelona, Spain): Endothelial cell
basal medium-2 supplemented with EGM Single Quots containing
hydrocortisone, 2% FBS, hFGF-B, VEGF, R3-IGF-1, ascorbic acid, hepa-
rin, FBS, hEGF, and GA-1000 (gentamicin, amphotericin-B). Mononu-
clear cells were seeded onto fibronectin-treated plates (2.5 lg/cm2;
Becton Dickinson) at a final density of 1.5 9 106 cells/cm2. Twenty-four
hours after seeding, non-adherent cells were removed and attached
cells were further cultured at 37°C and 5% of CO2. Culture media was
changed every 2 days until first EPC colonies appeared or up to a maxi-
mum of 40 days.
To test different culture conditions, some of the above-mentioned
parameters were modified. In this study, we tested two different FBS
media concentrations, 2% and 20%, as well as two different coating
matrixes, fibronectin 2.5 lg/cm2 and Gelatin 1% (Sigma-Aldrich, Tres
Cantos, Madrid, Spain).
Human umbilical vein endothelial cell culture
Human umbilical vein endothelial cell culture was isolated by collagenase
treatment of human umbilical veins from newborns as described earlier
[15]. Briefly, umbilical veins were flushed with sterile PBS solution
(Sigma-Aldrich) to wash the clotted blood out and then perfused with
1% collagenase solution and incubated at 37°C for 15 min. Endothelial
cells were recovered by centrifugation and seeded onto gelatin-treated
25 cm2 flasks (BioLite, LabClinics, Barcelona) in specific endothelial
media EGM-2.
Quantification of circulating EPC in peripheral
blood
Peripheral blood samples were recovered in heparin tubes and pro-
cessed within 2 hrs after extraction. Circulating EPC (cEPC) were
stained with anti-human VEGFR2/kinase insert domain receptor (KDR)
conjugated with phycoerythrin (PE; R&D Systems, Madrid, Spain),
fluorescein isothiocyanate (FITC)-conjugated anti-human CD34 (Becton
Dickinson) and peridinin chlorophyll protein complex (PerCP)-conju-
gated anti-human CD45 (Becton Dickinson) or with the appropriate is-
otype controls. Red blood cells were lysed (BD FACS Lysing solution,
Becton Dickinson) for 10 min. and stained cells were detected with a
FC5000 cytometer (Beckman-Coulter, Madrid, Spain) and results were
analysed with Infinicyt software (Cytognos S.A., Salamanca, Spain).
Circulating EPC were identified as negative for the leucocyte
marker CD45, positive for the prototypical stem cell marker CD34
and positive for the endothelial cell marker KDR (CD45CD34+KDR+)
[11].
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Endothelial progenitor cell characterization
Flow cytometry phenotypic characterization
Cultured EPC obtained under the most suitable conditions were also
characterized by flow cytometry. The expression of endothelial antigens
KDR and CD31 (also known as platelet-endothelial cell adhesion
molecule, PECAM-1), progenitor antigen CD34 and leucocyte antigen
CD45 was assessed. Briefly, harvested cells were stained with PE-conju-
gated anti-human KDR, FITC-conjugated anti-human CD31 or FITC-con-
jugated anti-human CD34 and PerCP-conjugated anti-human CD45, or
with the appropriate isotype controls. CD45, CD34 and CD31 antibodies
were purchased from Becton Dickinson and KDR antibody from R&D
Systems. Stained cells were detected with a FC5000 cytometer (Beck-
man-Coulter) and results were analysed with Infinicyt software (Cyto-
gnos S.A.). Cultured EPC were considered as negative for the leucocyte
marker CD45, positive for the stem-cell marker CD34 and positive for
the endothelial cell markers KDR and CD31 (CD45CD34+KDR+CD31+).
Immunofluorescence characterization
The ability of isolated EPC to uptake acetylated low density lipoprotein
(Ac-LDL) and to bind Ulex-lectin, the classical way to define endothelial
cells, was performed as described earlier [16,17]. Briefly, EPC were
incubated with 1,1′-dioctadecyl-3,3,3′,3′- tetramethylindo-carbocyanine–
labelled Ac-LDL (Dil-acLDL, Life Technologies, Alcobendas, Spain), fixed
with 4% paraformaldehyde and incubated with fluorescein isothiocya-
nate labelled Ulex europaeus agglutinin (FITC-UEA-1, Sigma-Aldrich).
Cell nuclei were stained with 4′,6-diamidino-2-phenylindole (DAPI,
Sigma-Aldrich). Stained samples were observed on a confocal spectral
Leica SP2 microscope (Leica, Barcelona, Spain). Pictures were taken
with a 409 objective and shown at 91200 magnification.
Endothelial progenitor cells cultures were also tested for von Wille-
brand Factor (vWF) expression. In brief, cells were fixed with 4% parafor-
maldehyde solution and permeabilized for with PBS 0.25% Triton X-100
solution. Cells were incubated first with rabbit polyclonal vWF antibody
(Abcam, Cambridge, United Kingdom) and then with a DyLight 488 con-
jugated anti-rabbit secondary antibody (Abcam). Counter staining was
achieved by incubating cells with DAPI. Images were obtained with an
inverted fluorescence microscope Nikon Eclispe Ti (1009 magnification).
Functional parameters
Cell growth curve
1.5 9 104 cells were seeded in EGM-2 media on each well, culture
media was changed daily and the counting process was repeated every
day for 6 days. Briefly, cells were detached by using 0.05% trypsin
solution, recovered by centrifugation and resuspended with 100 ll of
Tripan blue solution (Sigma-Aldrich). Cells were counted on a Neubauer
modified chamber and total number of cells per well were plotted to
calculate the lag period (latent period of no growth), the log phase
(when cells underwent exponential growth), the plateau (when growth
rate dropped close to zero) and the saturation density (at which the cell
population reached the plateau phase).
Cell proliferation
Cell proliferation was measured by flow cytometry with propidium iodide
(PI) staining (Immunostep, Salamanca, Spain) to quantify the content of
DNA and the distribution of a cell population along the different phases of
the cell cycle [18]. Briefly, cells were starved for 48 hrs and then stimu-
lated for 18 hrs with EGM-2 complete media. After incubation, cells were
detached with a 0.05% trypsin solution, fixed with 70% ethanol and
stained with PI-RNase solution (Immunostep). Stained cells were analy-
sed with FC5000 cytometer (Beckman-Coulter) and Infinicyt software
(Cytognos). Results are shown as percentage of cells undergoing DNA
synthesis plus mitosis with respect to total cell number analysed.
Cell adhesion
Adhesion assays were performed on fibronectin (Becton Dickinson)
treated dishes (2.5 lg/cm2). In brief, 5 9 104 cells were seeded on
dishes with a 4 mm2 grid (Nunc, Madrid, Spain) and incubated at 37°C
and 5% of CO2. After 30 min., non-adherent cells were removed and
adhered cells were counted in six random squares by two independent
observers. Data were expressed as a percentage of adhered cells rela-
tive to the total number of seeded cells.
Vasculogenesis assay
Vasculogenesis was analysed in Matrigel (Becton Dickinson) as previ-
ously described [19]. In brief, Matrigel was diluted with EGM-2 media
SBF free and allowed to solidify for 30 min. at 37°C. Thereafter,
1.5 9 105 cells/well were seeded and incubated for 8 hrs. Then, pic-
tures were taken with a Nikon Eclipse-Ti inverted microscope (Nikon,
Izasa, Valencia, Spain) with 49 objective (total magnification 409) and
images recorded by Nikon digital sight Ds-QiMc camera.
Images from five different random fields per well were processed
and analysed with Image Pro-Plus Software V.6 (Media Cybernetics,
Rockville, MD, USA). Total length data of the tube-like structures were
expressed in micrometers (lm).
Statistical analysis
Values shown in the text and figures are mean  SEM. For frequency
comparison, contingency tables were analysed by Chi-squared test. Data
normality was assessed by Kolmogorov–Smirnov test. Statistical com-
parisons were performed with one-way ANOVA for multiple comparisons
and then Bonferroni’s test was performed. Student’s t-test was applied
for single comparisons. Correlation analysis was performed by linear
regression. Growth curve data were analysed by two-way ANOVA with
Bonferroni’s post-test. P < 0.05 was considered significant. The statisti-
cal analysis was carried out by using the Prism 5.04 software (Graph-
Pad Software Inc., San Diego, CA, USA).
Results
EPC isolation conditions
Three clinically used anticoagulants were tested to study how the
anticoagulant used for blood sampling influences EPC isolation and
culture procedure. Identical blood volumes were recovered in tubes
containing EDTA, sodium heparin and sodium citrate. Mononuclear
cells from these samples were cultured and both the percentage of
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EPC cultures and the appearance mean time for the first EPC colonies
were recorded.
Only 20% of EDTA-recovered blood samples gave rise to EPC cul-
tures. However, when heparin or sodium citrate was used for blood
recovery, 80% of EPC cultures were successfully obtained (P < 0.01;
Fig. 1A). No significant differences were found with regard to EPC
appearance mean time between anticoagulants (Fig. 1B). Moreover,
100% of cultures derived from citrated samples showed different
morphology, were negative for the uptake of Ac-LDL and unable to
bind Ulex-lectin, thus demonstrating they were not EPC (Fig. S1).
Only heparin allows obtaining high yields of homogeneous EPC cul-
tures with the shorter appearance mean time. Thus, rest of the experi-
ments were performed with blood obtained with heparin as
anticoagulant.
To assess the effect of blood volume on EPC isolation proce-
dure, three different blood volumes (10, 20 and 30 ml) were tested.
The highest EPC culture yields, referred as the percentage of EPC
cultures obtained from blood samples, were found for blood sam-
ples of 30 ml (80%; P < 0.05 versus 10 ml). Although there were
no statistically significant differences between samples of 20 and
30 ml, the 20% yield reduction in 20 ml blood samples is worth
considering (Fig. 1B). The use of higher blood volumes for EPC iso-
lation showed a decrease in EPC appearance mean time, from
16 days for 10 ml blood samples to 12 days for both 20 and
30 ml blood samples (P < 0.05; Fig. 1C). On the basis of obtained
results, we chose to collect 30 ml of blood to reach high yields in
EPC cultures.
As quick blood processing is not always available, the effect of
time sampling on EPC isolation and culture procedure was checked
by dividing blood samples into two sets. One set was processed
within 2 hrs after extraction. The other set was left in a blood roller
mixer for 24 hrs and then processed in the same way (Fig. S2). For
samples processed within 2 hrs after withdrawal, 80% of EPC cul-
tures were obtained. For those samples left for 24 hrs in a blood
roller mixer, only 30% of EPC cultures were obtained (P < 0.05).
These results indicate the critical rapid processing of blood samples
when they are intended to EPC isolation.
EPC culture conditions
To investigate the role of the most common culture matrixes in the
cell culture procedure, MNC were seeded on culture plates previ-
ously treated with either gelatin or fibronectin. The highest number
of EPC cultures was obtained when fibronectin was used as coating
matrix (70% versus 20%; P < 0.05; Fig. 2A). A reduction in the
appearance time was also observed, from 23 days for gelatin matrix
to 12 days for fibronectin matrix (P < 0.01; Fig. 2B). Therefore, the
use of fibronectin matrix for EPC culture increases EPC culture
yields as well as it reduces the appearance mean time of the first
A B
C D
Fig. 1 Endothelial progenitor cells’ (EPC)
isolation conditions. (A) Effect of anticoag-
ulant in the success of EPC cultures and
(B) the time at which it was possible to
observe the first EPC colonies. Blood
samples were collected in tubes contain-
ing three different anticoagulants: ethylen-
ediaminetetraacetic acid (EDTA), heparin
and sodium citrate. EPC initial cultures
were followed up to 40 days of culture
(**P < 0.01 versus EDTA by Chi-squared
test; n = 10). Effect of blood volume in
the success of EPC cultures: bars repre-
sent (C) the percentages of EPC cultures
obtained from mononuclear cells obtained
from different blood volumes and (D) the
time at which it was possible to observe
the first EPC colonies (*P < 0.05 versus
10 ml; n = 10).
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EPC colonies. The rest of the experiments were performed onto
fibronectin-coated culture surfaces.
Two different concentrations of FBS, 2% and 20%, were tested as
complement to endothelial media EGM-2. The higher FBS concentra-
tion higher yield in EPC cultures is obtained (30% versus 70%;
Fig. 2C), although differences did not reach statistically significance
(P = 0.074). Endothelial progenitor cells appearance time, however,
was significantly reduced from 16 to 11 days (P < 0.05) for media
complemented with 2% and 20% FBS, respectively (Fig. 2D).
After testing different conditions for EPC isolation and culture, the
best combination of them all is the use of fibronectin as a coating
matrix, a minimum volume of 30 ml of fresh blood recovered in hepa-
rin tubes and EGM-2 supplemented with 20% FBS. Blood processing
within 2 hrs after extraction is also recommended. (Fig. S3 shows
bright field pictures of culture evolution from MNC seeding to EPC
confluent cultures).
EPC culture appearance time and circulating
levels of EPC
To test the relationship between cEPC and the success of its culture,
blood samples from 20 healthy donors were processed in two sets:
one for flow cytometry analysis for cEPC quantification, and the other
one for cell culture following the above-mentioned conditions, and
EPC culture yields and appearance time were recorded. With these
conditions, 15 EPC cultures were obtained and the EPC appearance
mean time was 13.5 days, in accordance with all the data presented
so far. The cEPC levels were 647  78 cEPC/ml of blood. Analysis of
blood samples data that successfully gave rise to EPC cultures
revealed that there was a significant, inverted correlation between
cEPC levels and appearance time (P < 0.01; Fig. 3).
Cultured EPC characterization
After isolation and culture procedure, obtained EPC cultures were
characterized morphologically. All EPC cultures showed the character-
istic endothelial cobblestone morphology. To ensure that our modified
procedure gave rise to true EPC, cells were phenotypically character-
ized by flow cytometry and immunofluorescence microscopy.
Flow cytometry immunophenotyping revealed that all isolated EPC
expressed endothelial markers CD31 and KDR. Panleucocyte marker
expression, CD45, was absent in all of them and progenitor marker
expression, CD34, was found in 45% of cultured cells (Fig. 4A).
Taken together, these results suggest our procedure allows the isola-
tion of EPC with endothelial-like phenotype.
The capacity of EPC cultures to incorporate Dil-acLDL and their
ability to bind FITC- UEA-1 were analysed in different cultures by
confocal microscopy (Fig. 4B). All the cultures were positive for both
A B
C D
Fig. 2 Endothelial progenitor cells’ (EPC) culture conditions. Effect of
culture matrix on the development of EPC cultures. Results represent
(A) the obtained EPC culture percentages from mononuclear cell (MNC)
seeded in plates coated with 1% gelatin or 2.5 lg/cm2 fibronectin
(*P < 0.05 by Chi-squared test; n = 10) and (B) EPC appearance time
(**P < 0.01 by Student’s t-test; n = 10). Effect of foetal bovine serum
(FBS) media concentration on the development of EPC cultures. Results
represent (C) the obtained EPC cultures from MNC maintained with
endothelial growing media-2 complete media supplemented with 2% or
20% FBS (n = 10) and (D) EPC appearance time (*P < 0.05 by Stu-
dent’s t-test; n = 10).
Fig. 3 Circulating endothelial progenitor cell (EPC) levels and EPC
appearance mean time relationship. Correlation between circulating EPC
levels and EPC cultures appearance mean time from mononuclear cell
derived from donors blood. Circulating EPC were analysed by flow
cytometry as CD45CD34+KDR+, as detailed in the Methods section
(R2 = 0.48; P < 0.01; n = 15).
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markers indicating an endothelial-like phenotype. Moreover, vWF
expression was also evaluated by fluorescence microscopy and all
the cells were uniformly positive for this marker (Fig. 4C).
Therefore, our modified culture procedure successfully achieves
the isolation of EPC with endothelial cell-like phenotype.
EPC functional parameters
To further confirm the excellence of obtained cultured EPC, the func-
tional ability of EPC in cultures was evaluated in terms of cell growth
kinetics, proliferation, adhesion and vasculogenesis. EPC functional
parameters were compared with those obtained for HUVEC, the well-
accepted endothelial cell model for studies in vitro.
Endothelial progenitor cells and HUVEC growth curves are pre-
sented in Figure 5A. Cells were counted every day until cells reached
confluence. Endothelial progenitor cells showed longer lag phase
(2.4 days) compared with HUVEC (1.3 days; P < 0.05). Endothelial
progenitor cells cultures were found to have shorter exponential
growth phase. Endothelial progenitor cells plateau growth phase was
reached on the 4th day after seeding at a saturation density of
5.2 9 105 cells/cm2. By contrast, HUVEC reached plateau growth
phase on the 5th day after seeding at a saturation density of
17.7 9 105 cells/cm2 (P < 0.001; Fig. 5A).
Cell proliferation was studied both in starvation and after stimula-
tion with complete EGM-2 media, after 48 hrs of starvation (Fig. 5B).
In starved conditions, about 10% of cells were proliferating. When
cells were stimulated with complete media, the percentage of cells
actively involved in proliferation was increased four- to sixfold
(P < 0.05 versus starvation). No differences in proliferation capacity
between EPC and HUVEC cultures were found under starvation condi-




Fig. 4 Cultured endothelial progenitor cells’ (EPC) phenotypic characterization. (A) Representative images for endothelial markers kinase insert
domain receptor (KDR) and CD31, the progenitor maker CD34 and the leucocyte antigen CD45 expression were assessed by flow cytometry. Grey
histograms are isotype-stained cells and black histograms represent cells positively stained with KDR, CD31, CD34 and CD45. The percentage of
EPC expressing each marker is presented as mean  SEM (n = 10). (B) Confocal microscopy of DiI-Ac-LDL uptake, FITC-UEA-1 binding, 4′,6-di-
amidino-2-phenylindole (DAPI) nuclei staining and merged images for EPC are shown. EPC were incubated with 2 lg/ml of Ac-LDL for 1 hr, fixed
with 4% paraformaldehyde and then incubated with 10 lg/ml FITC-Ulex-lectin. Counterstaining was achieved by 1 lg/ml DAPI staining. Scale bar
represents 25 lm (original magnification 91200). (C) Fluorescence microscopy of von Willebrand Factor expression, DAPI nuclei staining and
merged images for EPC are shown. EPC were incubated for 1 hr with 1:100 dilution of FITC-vWF. Scale bar represents 100 lm (original magnifica-
tion 9200). Images shown are representative of 10 EPC cultures.
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The cell adhesion function was evaluated by the cell ability to
adhere to an extracellular matrix of fibronectin for 30 min. Results
showed no differences between EPC and HUVEC (32% versus 35%,
respectively; Fig. 5C).
Vasculogenesis, the ability to form tube-like structures, was
assessed in vitro by seeding the cells on Matrigel matrix. All EPC and
HUVEC cultures were able to organize themselves into similar tube-
like structures (Fig. 5D). After 8 hrs of incubation, total length for
these structures was measured. Human umbilical vein endothelial
cells cultures formed larger tube-like structures (664  25 lm)
when compared with those formed by EPC cultures (394  92 lm;
P < 0.05; Fig. 5E).
Discussion
This study standardizes the most controllable conditions for optimal
isolation and culture of EPC from peripheral blood samples, the
less invasive source for EPC available so far. Our results point to
the need to control a number of parameters related to the sample
collection and to the culture conditions to obtain an optimal func-
tional performance of EPC. The conditions tested indicate (i)
peripheral blood should be recovered in heparin tubes; (ii) in a
minimum volume of 30 ml; (iii) blood samples should be pro-
cessed within 2 hrs after collection; (iv) fibronectin is the best
extracellular matrix and (v) culture media should be supplemented
with 20% FBS.
Knowledge of EPC biology represents an advance in the under-
standing of vascular repair mechanisms in physiological and
pathological situations. Furthermore, the fact of being able to suc-
cessfully isolate and culture EPC makes us closer to test them for
potential clinical applications in regenerative and anticancer thera-
pies [12, 13].
In this regard, the use of standard procedures for isolating and
culturing EPC is the only way to obtain comparable results. Different
culture procedures could lead to the isolation of different cell types
A B
C D E
Fig. 5 Cultured endothelial progenitor cells’ (EPC) functional characterization. (A) Growth curve of EPC and human umbilical vein endothelial cell (HU-
VEC) cultures followed up for 6 days. 15,000 cells were seeded on day one in 24-well plates and then counted daily. Results represent the number of
cells from each culture counted every day (***P < 0.001 versus EPC by two-way ANOVA and Bonferroni’s post- hoc test; n = 10). (B) Cell proliferation
of EPC and HUVEC after stimulation with full endothelial growing media (EGM)-2. EPC were starved for 48 hrs and then stimulated with complete
EGM-2 media for additional 18 hrs. Cells were harvested, stained with propidium iodide solution and measured by flow cytometry. Results represent
the number cells in proliferation (mitosis plus interphase) for EPC (white) and HUVEC (black), expressed as a percentage of total cells (*P < 0.05 ver-
sus same starved cell type by Student’s t-test; n = 10). (C) Cell adhesion of EPC and HUVEC. 50,000 cells were seeded on 2.5 lg/cm2 fibronectin-
treated dishes with 4 mm2 grid. Results represent the percentage of attached cells 30 min. after seeding as indicated in the Methods section
(n = 10). (D) The vasculogenesis capacity of EPC and HUVEC seeded on Matrigel is shown in the representative images of tube-like structures
formed by EPC and HUVEC (original magnification 940). 15,000 cells were seeded onto matrigel matrix diluted 1:1 with serum-free complete EGM-2
media and incubated for 8 hrs. (E) Total length analysis of tube-like structures for each sample (*P < 0.05 by Student’s t-test; n = 10).
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with very different properties. A good example of this fact is the great
difference in morphology, phenotype and behaviour between the so-
called early and late EPC where time is the main difference condition
for EPC culture and isolation (for a review, see [20]) Because of the
complex procedures for EPC isolation and culture, the comparison of
different works is quite challenging if not sometimes impossible.
There is a lack, however, of a methodical comparison of different
parameters for EPC isolation and culture.
Blood recovery and handling are an extremely important step in
EPC isolation as anticoagulants and sample timing handling may
affect EPC integrity. In some cases, other anticoagulants have been
used, although their effect on EPC isolation and culture yields, to our
knowledge, has not been systematically compared. Our results sug-
gest that correct sample handling would involve the use of heparin as
anticoagulant.
An important variable when using human samples, especially to
apply the procedure to patients in different circumstances, is the time
spent between blood sample collection and its processing. In our
study, a sample process time inferior to 2 hrs after withdrawal is
mandatory to obtain the highest EPC culture yields.
Regarding culture conditions, two important parameters demon-
strated an important impact on the probability to obtain an EPC cul-
ture and the mean appearance time. On the one hand, the use of
fibronectin as matrix to coat cell culture superficies triplicated the
success and half-reduced the appearance time, in agreement with
previous reports where EPC showed a greater adherence on fibronec-
tin matrix than collagen [1]. On the other hand, the FBS, which is
commonly added to cell culture media as a source of growth factors,
cytokines and essential nutrients, is also critical to increase the likeli-
hood to obtain EPC cultures and to reduce the EPC appearance mean
time.
As previously reported, the volume used to isolate EPC from
peripheral blood samples ranged from 50 to 100 ml [14, 21]. How-
ever, a minor volume of blood sample of 20 ml was required when
the origin was human umbilical cord blood samples [14] probably
because of a higher content in progenitor cells. Taken together, our
results suppose a reduction in blood sample volumes and culture
mean time than those found earlier for peripheral blood samples and
a significant increase in the success rates (compared to 13%
achieved in other studies [22]).
Circulating EPC levels change with several physiological condi-
tions, such as menopause [23], physical training or ageing [24].
Acute disorders, such as myocardial infarction [25] or vascular
trauma [26], increase the number of circulating EPC in blood sam-
ples. Conversely, an inverse correlation between EPC number and risk
factors has been described in coronary artery disease [27].
The present study demonstrated an inverse correlation between
the number of cEPC and EPC appearance mean time in culture,
suggesting that the higher the number of circulating EPC in blood
samples, the higher is the likelihood and the shorter the time to
successfully obtain EPC cultures out of them. This information is
of great importance if our proposed procedure is intended for
EPC isolation, culture and cell therapy. In this case, previous EPC
mobilization would be strongly recommended to ensure high
yields and time reduction in EPC cultures, particularly in those
pathologies where EPC numbers have been reported to be reduced
[27].
But not only is the yield of the method important but the func-
tional characteristics of the obtained EPC. The morphological, pheno-
typical and functional characteristics of cultured EPC were
comparable to endothelial cells from other sources, such as HUVEC.
Cultured EPC showed a cobblestone-like morphology was positive for
LDL uptake and Ulex-lectin binding, expressed progenitor antigen
CD34 as well as endothelial antigens CD31, KDR, vWF while lack the
expression of hematopoietic marker CD45. Our procedure give rise to
EPC with similar traits to the so-called late EPC, endothelial colony
forming cells or endothelial outgrowth cells [11, 14, 20, 21].
Endothelial progenitor cells obtained under the best conditions
exhibited functional parameters comparable to those obtained for
HUVEC in terms of growth curve, cell proliferation and adhesion
and vasculogenesis. In spite of cultured EPC showed reduced
growth (which can be attributed to the longer lag phase) and vas-
culogenic capabilities than HUVEC, no differences were found in
proliferative and adhesive capabilities between these two cell types.
Therefore, the culture conditions provided are not only an adequate
tool to study EPC but also a source of endothelial cells from
adults.
The agreement on EPC definition (CD34+KDR+ phenotype) repre-
sents the best compromise in terms of detection accuracy, biological
meaning and clinical usefulness [28], as well as the development of
standardized procedures for EPC isolation and culture opens the use
of EPC for clinical application.
In summary, we presented a standard protocol for EPC isolation
and culture from human peripheral blood. Additional in vivo testing of
the isolated EPC following our procedure must be performed to fully
characterize the possible potential of this cell population for cell ther-
apy use and regenerative medicine.
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Figure S1 Phenotypic characterization of cells isolated from citrate
tube collected blood. Bright field images of cell cultures (A) 940 and
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(B) 9200 magnification. Fluorescence microscopy of DiI-Ac-LDL
uptake (C), FITC-UEA-1 binding (D), DAPI nuclei staining (E) and
merged images (F) are shown. Cells were incubated with 2 lg/ml of
Ac-LDL for 1 hr, fixed with 4% paraformaldehyde and then incubated
with 10 lg/ml FITC-Ulex-lectin. Counterstaining was achieved by
1 lg/ml DAPI staining. Scale bar represents 100 lm (original magni-
fication for fluorescence microscopy images: 9200).
Figure S2 Influence of processing time on the success of
EPC cultures. Blood samples were divided into two sets. One
was processed within 2 hrs and the other 24 hrs after with-
drawal. The success of EPC culture was expressed as the
percentage of EPC cultures obtained (*P < 0.05 by Chi-squared
test; n = 10).
Figure S3 MNC culture and EPC isolation. Representative
images of EPC cultures. (A) MNC after seeding. After 24 hrs of
incubation, non-adhered cells were removed and attached cells
(B) were further cultivated. On day 15 of culture, first EPC colo-
nies appeared (C). EPC colonies were cultured for 7 days or
until they reached confluence (D). All the pictures above shown
were taken at 9100 magnification.
Table S1 Characteristics of healthy individuals.
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